Nutrition for the Prevention and Treatment of Chronic Kidney Disease in Diabetes

Canadian Journal of Diabetes

Volumn 38, Issue 5, 2014, Pages 344-348

  Whitham, Dana ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Diabetes; Nephropathy; Nutrition; Protein; Sodium

Indexed keywords

ADVANCED GLYCATION END PRODUCT; INSULIN; INSULIN DERIVATIVE; OMEGA 3 FATTY ACID; SWEETENING AGENT;

ALBUMINURIA; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIET THERAPY; DIETARY COMPLIANCE; DIETARY FIBER; END STAGE RENAL DISEASE; FAT INTAKE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; HYPERVOLEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALNUTRITION; NUTRITIONAL COUNSELING; OBESITY; POTASSIUM RESTRICTION; PROTEIN RESTRICTION; PROTEINURIA; REVIEW; SODIUM RESTRICTION; UREMIA; WAIST CIRCUMFERENCE; WATER DEPRIVATION; WEIGHT REDUCTION; ATTITUDE TO HEALTH; CANADA; DIABETIC NEPHROPATHIES; DIET; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEEDING BEHAVIOR; INFLAMMATION; NUTRITIONAL STATUS; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC; RISK REDUCTION;

CANADA; DIABETIC NEPHROPATHIES; DIET; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FOOD HABITS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLAMMATION; NUTRITIONAL STATUS; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC; RISK REDUCTION BEHAVIOR; WEIGHT LOSS;

EID: 84923204236     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2014.07.222     Document Type: Review

References (37)

1. Gaede P., Lund-Anderson H., Parving H.H., Pederson O. Effect of a multi-factorial intervention on mortality in T2DM (Steno-2). NEngl J Med 2008, 358:580-591.
2. Peppa M., Raptis S.A. Advanced glycation end products and cardiovascular disease. Curr Diabetes Rev 2008, 4:92-100.
3. American Diabetes Association: Standards of Medical Care in Diabetes, 2012. Diabetes Care 2012, 35(Suppl 1):S11-S63.
4. Wang Y., Chen X., Song Y., et al. Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int 2008, 73:19-33.
5. Munkhaugen J., Lydersen S., Wideroe T.E., Hallan S. Prehypertension, obesity and risk of kidney disease: 20 year follow-up of the HUNT 1 study in Norway. Am J Kidney Dis 2009, 54:638-646.
6. National Kidney Foundation: KDOQI clinical practice guidelines for diabetes and chronic kidney disease. Am J Kidney Dis 2012, 49(Suppl 2):S1-S179.
7. Schwarz S., Trivedi B.K., Kalantar-Zadeh K., Kovesdy C.P. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006, 1:825-831.
8. Mehrotra R., Peralta C.A., Chen S., et al. No independent association of serum phosphorus with risk of death or progression to end stage renal disease in a large screen for chronic kidney disease. Kidney Int 2013, 84:989-997.
9. Uribarri J., Woodruff S., Goodman S., et al. Advanced glycation end products in foods: a practical guide to their reduction in the diet. JAm Diet Assoc 2010, 110:911-916.
10. Stirban A, Negrean M, Götting C, etal. Dietary advanced glycation end and oxidative stress: Invivo effects on endothelial dysfunction and adipokines. Ann N Y Acad Sci 2008;1126:276-279.
11. Mima A. Inflammation and oxidative stress in diabetic nephropathy: New insights on its inhibition as new therapeutic targets. JDiabetes Res 2013, Epub June 3, 2013.
12. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2013, 37(Suppl 1):S1-S212.
13. Morales E., Valero M.A., León M., et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003, 41:319.
14. American Dietetic Association Guide to Diabetes Medical Nutrition Therapy and Education by the Diabetes Care and Education Dietetic Practice Group 2005, American Dietetic Association, Chicago. T.A. Ross, J.L. Boucher, B.S. O'Connell (Eds.).
15. Maggio C.A., Pi-Sunyer F.X. Obesity and type 2 diabetes. Endocrinol Metab Clin North Am 2003, 32:805-822.
16. Saiki A., Nagayama D., Ohhira M., et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes (Lond) 2005, 29:1115.
17. Afshinnia F., Wilt T.J., Duval S., et al. Weight loss and proteinuria: Systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010, 25:1173-1183.
18. Sanches F.M.R., Avesani C.M., Kamimura M.A., et al. Waist circumference and visceral fat in CKD: A cross-sectional study. Am J Kidney Dis 2008, 52:66-73.
19. Academy of Nutrition and Dietetics. Evidence-based nutrition practice guideline on chronic kidney disease. Accessed 2014 February 24. http://andevidencelibrary.com.
20. National Kidney Foundation KDOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 2003, 41:S1-S92.
21. Anderson T.J., Grégoire J., Hegele R.A., et al. 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol 2013, 29:151-167. 10.1016/j.cjca.2012.11.032.
22. The ORIGIN Trial Investigators. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. NEngl J Med 2012, 367:309-318.
23. Gradual N.A., Hubeck-Graudal T., Jurgens G. Effects on low sodium diets vs. high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol and triglyceride (Cochrane review). Am J Hypertens 2012, 25:1-15.
24. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013, 3(Suppl):5-14.
25. Daskalopoulou S.S., Khan N.A., Quinn R.R., et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy. Can JCardiol 2012, 28:270-287.
26. National Kidney Foundation KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004, 43(Suppl 1):S115-S119.
27. Nutrition recommendation and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl 1):S61-S72.
28. Sheard N.F., Clark N.G., Brand-Miller J.C., et al. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: A statement of the American Diabetes Association. Diabetes Care 2004, 27:2226-2271.
29. Fitch C., Keim K.S. Position of the Academy of Nutrition and Dietetics: Use of nutritive and non-nutritive sweeteners. JAcad Nutr Diet 2012, 112:739-758.
30. Nuttall F.Q., Gannon M.C. Metabolic response of people with type 2 diabetes to a high protein diet. Nutr Metab (Lond) 2004, 1:6.
31. Pedrini M.T., Levey A.S., Lau J., et al. The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: A meta-analysis. Ann Intern Med 1996, 124:627-632.
32. Kasiske B.L., Lakatua J.D., Ma J.Z., Louis T.A. Ameta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998, 31:954-961.
33. Klahr S. Modification of diet in renal disease. NEngl J Med 1989, 30(320):864-866.
34. Robertson L.M., Waugh N., Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev 2007, 4.
35. Pan Y., Guo L.L., Jin H.M. Low-protein diet for diabetic nephropathy: A meta-analysis of randomized controlled trials. Am J Clin Nutr 2008, 88:660-666.
36. Hansen H.P., Tauber-Lassen E., Jensen B.R., Parving H.H. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002, 62:220-228.
37. Whitham D, Sharma Parpia A. 2014. Diabetes mellitus and chronic kidney disease (stages 1-5). In Byham-Gray L, Burrowes J, Chertow GM (eds.). Nutrition in Kidney Disease, 2nd edn. New York: Humana Press.